Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth

Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth Optimization of Peptides That Target Human Thymidylate Synthase to Inhibit Ovarian Cancer Cell Growth Internalization and Stability of a Thymidylate Synthase Peptide Inhibitor in Ovarian Cancer Cells Bicyclic thiazolidine lactam peptidomimetics of the dopamine receptor modulating peptide Pro-Leu-Gly-NH2 Pseudoprolines as stereoelectronically tunable proline isosteres Development of methotrexate proline prodrug to overcome resistance by MDA-MB-231 cells Use of lantibiotic synthetases for the preparation of bioactive constrained peptides Antineoplastic Agents. 515. Synthesis of Human Cancer Cell Growth Inhibitors Derived from 3,4-Methylenedioxy-5,4‘-dimethoxy-3‘-amino-Z-stilbene A cell-penetrating peptidic GRP78 ligand for tumor cell-specific prodrug therapy Synthesis, molecular docking and anticancer studies of peptides and iso-peptides